NCT00681369

Brief Summary

the purpose of this study is to describe the way Faslodex is used in France, in patients suffering from initial breast cancer, that is to evaluate Faslodex treatment duration and to determine patients profile

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
217

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2007

Shorter than P25 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2007

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2007

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

May 20, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 21, 2008

Completed
Last Updated

January 24, 2011

Status Verified

January 1, 2011

First QC Date

May 20, 2008

Last Update Submit

January 21, 2011

Conditions

Breast Cancer

Keywords

breast cancerfulvestrantlongitudinal studyFrance

Outcome Measures

Primary Outcomes (2)

  • Evaluate Faslodex therapeutic strategy and treatment duration

    At the end of the study

  • Describe the characteristics of patients treated with Faslodex

    At the end of the study

Study Arms (1)

1

Patients suffering from initial breast cancer, treated with Faslodex, treatment which was stopped during 2007

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Hospital sample

You may qualify if:

  • Patients suffering from initial breast cancer, treated with Faslodex, treatment which was stopped during 2007

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Alain FLINOIS

    TNS Healthcare - France138, avenue Marx Dormoy92120 Montrouge

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

May 20, 2008

First Posted

May 21, 2008

Study Start

May 1, 2007

Study Completion

June 1, 2007

Last Updated

January 24, 2011

Record last verified: 2011-01